We are live on ! Find out more
CDIO icon

Cardio Diagnostics

16 hedge funds and large institutions have $996K invested in Cardio Diagnostics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

14% more funds holding

Funds holding: 1416 (+2)

0% more ownership

Funds ownership: 0.26%0.27% (+0%)

57% less capital invested

Capital invested by funds: $2.3M → $996K (-$1.31M)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CDIO Hedge Fund Activity: Q2 2024 in Review

16 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q2 2024, worth a combined $996K — down 57% from $2.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CDIO positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $61.5K. The largest seller was Vontobel Holding, exiting entirely with an estimated $17K sold.

  • 16 institutional investors held Cardio Diagnostics (CDIO) as of Q2 2024, up from 14 in Q1 2024.
  • Funds reported $996K of Cardio Diagnostics stock for Q2 2024, down 57% quarter-over-quarter.
  • 4 funds opened new Cardio Diagnostics positions in Q2 2024 and 2 closed out, a net change of +2 holders.
  • The largest Cardio Diagnostics buyer in Q2 2024 was UBS Group, an estimated $61.5K added.
  • The largest Cardio Diagnostics seller in Q2 2024 was Vontobel Holding, an estimated $17K sold.

Based on aggregated 13F filings for Q2 2024.